
<ns0:uwmetadata xmlns:ns0="http://phaidra.univie.ac.at/XML/metadata/V1.0" xmlns:ns1="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0" xmlns:ns10="http://phaidra.univie.ac.at/XML/metadata/provenience/V1.0" xmlns:ns11="http://phaidra.univie.ac.at/XML/metadata/provenience/V1.0/entity" xmlns:ns12="http://phaidra.univie.ac.at/XML/metadata/digitalbook/V1.0" xmlns:ns13="http://phaidra.univie.ac.at/XML/metadata/etheses/V1.0" xmlns:ns2="http://phaidra.univie.ac.at/XML/metadata/extended/V1.0" xmlns:ns3="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/entity" xmlns:ns4="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/requirement" xmlns:ns5="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/educational" xmlns:ns6="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/annotation" xmlns:ns7="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/classification" xmlns:ns8="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/organization" xmlns:ns9="http://phaidra.univie.ac.at/XML/metadata/histkult/V1.0">
  <ns1:general>
    <ns1:identifier>o:1806</ns1:identifier>
    <ns1:title language="en">Transcriptome Profiling of Porcine Naïve, Intermediate and Terminally Differentiated CD8+ T Cells</ns1:title>
    <ns1:language>en</ns1:language>
    <ns1:description language="en">The pig has the potential to become a leading research model for human diseases, pharmacological and transplantation studies. Since there are many similarities between humans and pigs, especially concerning anatomy, physiology and metabolism, there is necessity for a better understanding of the porcine immune system. In adaptive immunity, cytotoxic T lymphocytes (CTLs) are essential for host defense. However, most data on CTLs come from studies in mice, non-human primates and humans, while detailed information about porcine CD8+ CTLs is still sparse. Aim of this study was to analyze transcriptomes of three subsets of porcine CD8β+ T-cell subsets by using next-generation sequencing technology. Specifically, we described transcriptional profiles of subsets defined by their CD11a/CD27 expression pattern, postulated as naïve (CD8β+CD27+CD11alow), intermediate differentiated (CD8β+CD27dimCD11a+), and terminally differentiated cells (CD8β+CD27-CD11ahigh). Cells were analyzed in ex vivo condition as well as upon in vitro stimulation with concanavalin A (ConA) and PMA/ionomycin. Our analyses show that the highest number of differentially expressed genes was identified between naïve and terminally differentiated CD8+ T-cell subsets, underlining their difference in gene expression signature and respective differentiation stages. Moreover, genes related to early (IL7-R, CCR7, SELL, TCF7, LEF1, BACH2, SATB1, ZEB1 and BCL2) and late (KLRG1, TBX21, PRDM1, CX3CR1, ZEB2, ZNF683, BATF, EZH2 and ID2) stages of CD8+ T-cell differentiation were highly expressed in the naïve and terminally differentiated CD8+ T-cell subsets, respectively. Intermediate differentiated CD8+ T-cell subsets shared a more comparable gene expression profile associated with later stages of T-cell differentiation. Genes associated with cytolytic activity (GNLY, PRF1, GZMB, FASL, IFNG and TNF) were highly expressed in terminally and intermediate differentiated CD8+ T-cell subsets, while naïve CD8+ T cells lacked expression even after in vitro stimulation. Overall, PMA/ionomycin stimulation induced much stronger upregulation of genes compared to stimulation with ConA. Taken together, we provided comprehensive results showing transcriptional profiles of three differentiation stages of porcine CD8+ T-cell subsets. In addition, our study provides a powerful toolbox for the identification of candidate markers to characterize porcine immune cell subsets in more detail.</ns1:description>
    <ns1:keyword language="en">Cytotoxic-T; Effector; Memory; Expression; Receptor; Subsets; Virus; Lymphocytes; Infection; Responses</ns1:keyword>
    <ns2:identifiers>
      <ns2:resource>1552099</ns2:resource>
      <ns2:identifier>10.3389/fimmu.2022.849922</ns2:identifier>
    </ns2:identifiers>
  </ns1:general>
  <ns1:lifecycle>
    <ns1:upload_date>2023-07-07T07:41:54.910Z</ns1:upload_date>
    <ns1:status>44</ns1:status>
    <ns2:peer_reviewed>yes</ns2:peer_reviewed>
    <ns1:contribute seq="0">
      <ns1:role>46</ns1:role>
      <ns1:entity seq="0">
        <ns3:firstname>Emil</ns3:firstname>
        <ns3:lastname>Lagumdzic</ns3:lastname>
        <ns3:institution>University of Veterinary Medicine Vienna</ns3:institution>
        <ns3:orcid>0000-0002-0347-7125</ns3:orcid>
      </ns1:entity>
      <ns1:entity seq="5">
        <ns3:firstname>Clara</ns3:firstname>
        <ns3:lastname>Pernold</ns3:lastname>
        <ns3:institution>University of Veterinary Medicine Vienna</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="6">
        <ns3:firstname>Marta</ns3:firstname>
        <ns3:lastname>Viano</ns3:lastname>
        <ns3:institution>Istituto di Ricerche Biomediche &quot;A. Marxer&quot; RBM S.p.A.</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="4">
        <ns3:firstname>Simone</ns3:firstname>
        <ns3:lastname>Olgiati</ns3:lastname>
        <ns3:institution>Istituto di Ricerche Biomediche &quot;A. Marxer&quot; RBM S.p.A.</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="3">
        <ns3:firstname>Michael W.</ns3:firstname>
        <ns3:lastname>Schmitt</ns3:lastname>
        <ns3:institution>Merck Healthcare KGaA</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="1">
        <ns3:firstname>Kerstin H.</ns3:firstname>
        <ns3:lastname>Mair</ns3:lastname>
        <ns3:institution>University of Veterinary Medicine Vienna</ns3:institution>
        <ns3:type>person</ns3:type>
        <ns3:orcid>0000-0002-3538-8303</ns3:orcid>
      </ns1:entity>
      <ns1:entity seq="2">
        <ns3:firstname>Armin</ns3:firstname>
        <ns3:lastname>Saalmüller</ns3:lastname>
        <ns3:institution>University of Veterinary Medicine Vienna</ns3:institution>
        <ns3:type>person</ns3:type>
        <ns3:orcid>0000-0002-7703-3252</ns3:orcid>
      </ns1:entity>
    </ns1:contribute>
  </ns1:lifecycle>
  <ns1:technical>
    <ns1:format>application/pdf</ns1:format>
    <ns1:size>6679833</ns1:size>
    <ns1:location>https://phaidra.vetmeduni.ac.at/o:1806</ns1:location>
  </ns1:technical>
  <ns1:rights>
    <ns1:cost>no</ns1:cost>
    <ns1:copyright>yes</ns1:copyright>
    <ns1:license>16</ns1:license>
  </ns1:rights>
  <ns1:classification>
    <ns1:purpose>70</ns1:purpose>
  </ns1:classification>
  <ns1:organization>
    <ns8:hoschtyp>1552253</ns8:hoschtyp>
  </ns1:organization>
  <ns12:digitalbook>
    <ns12:name_magazine language="en">Frontiers in Immunology</ns12:name_magazine>
    <ns12:pagination>17</ns12:pagination>
    <ns12:volume>13</ns12:volume>
    <ns12:publisher>Frontiers Media Sa</ns12:publisher>
    <ns12:releaseyear>2022</ns12:releaseyear>
  </ns12:digitalbook>
</ns0:uwmetadata>
